- Published at
- by gurufocus.com
mixed
mixed
Arcellx Provides First Quarter 2025 Financial Results and Business Highlights
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer a